Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance

Mostrar otras versiones (1)

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers based on five-year survival rates. Genes contributing to chemoresistance represent novel therapeutic targets that can improve treatment response. Increased expression of ANGPTL4 in tumors correlates with poor outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Emily R., Wright, Carter A., James, Mikayla, Cooper, Sara J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251551/
https://www.ncbi.nlm.nih.gov/pubmed/37291514
http://dx.doi.org/10.1186/s12885-023-11010-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251551/
https://www.ncbi.nlm.nih.gov/pubmed/37291514
http://dx.doi.org/10.1186/s12885-023-11010-1

Ejemplares similares